SEC Filings

DEFR14A
MEDTRONIC PLC filed this Form DEFR14A on 10/11/2017
Entire Document
 

Corporate Governance Highlights

 

Strong Lead Independent Director

See page 19

 

Annual Board and Committee
Evaluation Processes

See page 20

 

Robust Risk Management Program

See page 19

         

Stock Ownership Guidelines for
Named Executive Officers and Directors

See pages 20 and 47

 

Annual Board of Director Elections and
Majority Voting for Directors

See page 12

 

Regular Executive Sessions of
Independent Directors

See page 19

 

Realigned Board Committees and
Chair Assignments

See page 21

 

Sustainability and Citizenship Highlights

See page 10

  Proxy Access
         

High Ethical Standards Established in Written Policies and Actions (Includes Codes of Conduct, U.S. Patient Privacy Principles, Political Contribution Policy, and Policies Regarding Environmental, Health and Safety and the Use of Animals)

See page 27 and our investor relations website

 

2017 Board Composition

 

 

Shareholder Outreach on Governance

 

We recognize the value of shareholder engagement and take a proactive approach to shareholder outreach on governance matters. We continuously engage with our shareholders, including investment and governance specialists, to seek input on governance, executive compensation, strategic issues and to address their questions and concerns. We bring feedback from our shareholders to our Board; such feedback is instrumental to the Board’s decision-making process.

 

ENGAGEMENT CYCLE

 

 

MEDTRONIC PLC   2017 Proxy Statement    7

 
X